CRP and neoplasm: Using the following prognostic factors, the MMPS could distinguish patients with different prognosis in terms of OS: tumor volume pre-chemotherapy (pre-CTX) > 500 ml, CRP pre-CTX > 30 mg/l, non-epithelioid histology in pre-CTX biopsy, and progressive disease according to modified RECIST criteria [21].